New Reagent Delivers Improved Sensitivity, Simplifies Selection
Hercules, CA — July 19, 2016 — Bio-Rad Laboratories Inc. (NYSE: BIO and BIOb) today announced the launch of Clarity Max Western ECL Substrate, an enhanced chemiluminescent (ECL) detection reagent that provides superior performance for low-abundance proteins, whether using film or digital detection systems.
Selecting the best western blotting detection substrate can be difficult because most available substrates are highly specialized, forcing researchers to choose what they hope is the best option among a family of five or more. Because it is nearly impossible to determine protein expression levels prior to detection, researchers are often left to guess which substrate will provide the optimal result.
“Companies typically offer a complex portfolio of four to five western blotting substrates,” said Scott Chilton, Bio-Rad product manager for electrophoresis/western blotting. “Bio-Rad’s Clarity family of western ECL substrates simpliﬁes the search for the right substrate. Clarity is the choice for most western blotting experiments, and now Clarity Max is available when higher sensitivity is needed to visualize low-abundance proteins.”
Clarity Max Western ECL Substrate can detect proteins at mid- to low-femtogram levels, and the substrate generates clean blots that offer bright bands and low background. It can be used with nitrocellulose, PVDF, and low-fluorescence PVDF membrane and is compatible with film and charged-couple device (CCD) imaging systems. Clarity Max Substrate is easy to store and handle, offering a one-year shelf life when stored at room temperature.
For product details or to order Clarity Max Western ECL Substrate, visit www.bio-rad.com/IntroducingClarityMax.
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) develops, manufactures, and markets a broad range of innovative products and solutions for the life science research and clinical diagnostic markets. The company is renowned for its commitment to quality and customer service among university and research institutions, hospitals, public health and commercial laboratories, as well as the biotechnology, pharmaceutical, and food safety industries. Founded in 1952, Bio-Rad is based in Hercules, California, and serves more than 100,000 research and healthcare industry customers through its global network of operations. The company employs more than 7,800 people worldwide and had revenues exceeding $2 billion in 2015. For more information, please visit www.bio-rad.com.
For more information contact:
Product Manager — Electrophoresis/Western Blotting
Bio-Rad Laboratories, Inc.